Florastor (Saccharomyces boulardii) is Effective During 14-Day Antibiotic Treatment
Florastor (Saccharomyces boulardii) probiotic is recommended for patients taking antibiotics for 14 days to reduce the risk of antibiotic-associated diarrhea and C. difficile infection. 1
Evidence for Effectiveness
Saccharomyces boulardii has strong evidence supporting its use during antibiotic therapy:
- Meta-analyses demonstrate that S. boulardii significantly reduces the risk of antibiotic-associated diarrhea (AAD) from 17.2% to 6.7% 2
- The number needed to treat (NNT) to prevent one case of AAD is 10 2
- S. boulardii can mitigate antibiotic-induced dysbiosis (disruption of gut microbiota) 3
- Unlike bacterial probiotics, S. boulardii is a yeast and therefore not directly affected by antibiotics, making it particularly suitable for administration during antibiotic treatment 4
Timing and Duration
For optimal effectiveness:
- Start Florastor within 48 hours of beginning antibiotic therapy 3
- Continue throughout the 14-day antibiotic course
- For best results, continue Florastor for 7 days after completing antibiotics to help restore normal gut flora 3
Mechanism of Action
Florastor helps prevent antibiotic-associated complications through several mechanisms:
- Competes with pathogenic bacteria
- Modulates local and systemic immune responses
- Improves gut barrier function
- Promotes restoration of normal gut microbiota 1, 3
Specific Benefits During Antibiotic Therapy
- Reduced risk of antibiotic-associated diarrhea (AAD) 1, 5
- Prevention of Clostridioides difficile infection 1
- Fewer gastrointestinal adverse events from antibiotics 3
- Better tolerance of antibiotic regimens 3
- Less pronounced microbiota disruption including reduced overgrowth of potentially harmful bacteria like Escherichia 3
Important Considerations
- Efficacy is strain-specific - ensure you're using genuine Saccharomyces boulardii CNCM I-745 (Florastor) 4
- Take Florastor at least 2 hours apart from antibiotic doses
- While generally safe, avoid in severely immunocompromised patients 1
- Not all probiotics are equally effective during antibiotic therapy; S. boulardii has particularly strong evidence 1
Potential Limitations
A 2012 study in elderly hospitalized patients did not show effectiveness in preventing AAD 6, but this contradicts multiple other studies and meta-analyses showing benefit 5, 2. The weight of evidence supports using S. boulardii during antibiotic therapy, particularly in outpatient settings.
Florastor represents one of the most evidence-based approaches to mitigating antibiotic-associated complications and is appropriate for a 14-day course of antibiotics.